Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation

Journal of Applied Toxicology

Volumn 31, Issue 1, 2011, Pages 63-74

  Kojima, Hajime ^a   Takeyoshi, Masahiro ^b   Sozu, Takashi ^c   Awogi, Takumi ^d   Arima, Kazunori ^e   Idehara, Kenji ^f   Ikarashi, Yoshiaki ^a   Kanazawa, Yukiko ^g   Maki, Eiji ^h   Omori, Takashi ⁱ   Yuasa, Atsuko ^j   Yoshimura, Isao ^k  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b CHEMICALS EVALUATION AND RESEARCH INSTITUTE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e TAISHO PHARMACEUTICAL CO LTD   (Japan)

^f DAICEL CORPORATION   (Japan)

^g HATANO RESEARCH INSTITUTE   (Japan)

^h Biosafety Research Center   (Japan)

ⁱ KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^j FUJIFILM CORPORATION   (Japan)

^k TOKYO UNIVERSITY OF SCIENCE   (Japan)

more..

Author keywords

5 bromo 2' deoxyuridine (BrdU); Inter laboratory validation study; Local lymph node assay (LLNA); Skin sensitization; Stimulation Index (SI)

Indexed keywords

BROXURIDINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; FEMALE; LOCAL LYMPH NODE ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SKIN SENSITIZATION; VALIDATION STUDY;

ANIMALS; BROMODEOXYURIDINE; DERMATITIS, ALLERGIC CONTACT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LABORATORIES; LOCAL LYMPH NODE ASSAY; MICE; MICE, INBRED CBA; ORGANIC CHEMICALS; QUALITY CONTROL; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

CAVIA; MURINAE;

EID: 78650470088     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1567     Document Type: Article

References (41)

1. Basketter DA, Scholes EW. 1992. Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens. Food Chem. Toxicol. 30: 65-69.
2. Basketter DA, Scholes EW, Kimber I, Botham PA, Hilton J, Miller K. 1991. Interlaboratory evaluation of the local lymph node assay with 25 chemicals and comparison with guinea pig test data. Toxicol. Meth. 1: 30-43.
3. Basketter DA, Gerberick GF, Kimber I, Loveless SE. 1996. The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem. Toxicol. 34: 985-997.
4. Basketter DA, Gerberick GF, Kimber I. 1998. Strategies for identifying false positive responses in predictive skin sensitization tests. Food Chem. Toxicol. 36: 327-333.
5. Basketter DA, Lea LJ, Cooper KJ, Ryan CA, Gerberick GF, Dearman RJ. 1999a. Identification of metal allergens in the local lymph node assay. Am. J. Contact Dermat. 10: 207-212.
6. Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I. 1999b. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 19: 261-266.
7. Basketter DA, Blaikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJ. 2000. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermat. 42: 344-348.
8. Basketter DA, Evans P, Fielder RJ, Gerberick GF, Dearman RJ, Kimber I. 2002. Local lymph node assay- Validation, conduct and use in practice. Food Chem. Toxicol. 40: 593-598.
9. Basketter DA, Casati S, Gerberick GF, Griem P, Philips B, Worth A. 2005. Skin sensitisation. Altern. Lab. Anim. 33(suppl. 1): 83-103.
10. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. II. Conclusions and recommendations of an independent scientific peer review panel. Regul. Toxicol. Pharmacol. 34: 258-273.
11. Dearman RJ, Hilton J, Basketter DA, Kimber I. 1999. Cytokine endpoints for the local lymph node assay: Consideration of interferon-g and interleukin 12. J. Appl. Toxicol. 19: 149-155.
12. Durand G, De Burlet G, Virat M, Nauman BD. 2003. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates. Contact Dermat. 49: 148-154.
13. Ehling G, Hecht M, Heusener A, Huesler J, Gamer AO, van Loveren H, Maurer T, Riecke K, Ullmann L, Ulrich P, Vandebriel R, Vohr HW. 2005a. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round. Toxicology 212: 60-68.
14. Ehling G, Hecht M, Heusener A, Huesler J, Gamer AO, van Loveren H, Maurer T, Riecke K, Ullmann L, Ulrich P, Vandebriel R, Vohr HW. 2005b. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round. Toxicology 212: 69-79.
15. FDA. 2002. Guidance for Industry-Immunotoxicology Evaluation of Investigational New Drugs.
16. Gad SC, Dunn BJ, Dobbs DW, Relly C, Walsh RD. 1986. Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol. Appl.Pharmacol. 84: 93-114.
17. Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA. 2000. Local lymph node assay: validation assessment for regulatory purposes. Toxicology 11: 3-18.
18. Gerberick GF, Ryan CA, Kern PS, Dearman RJ, Kimber I, Patlewicz GY, Basketter DA. 2004. A chemical dataset for evaluation of alternative approaches to skinsensitization testing. Contact Dermat. 50: 274-288.
19. Haneke KE, Tice RR, Carson BL, Margolin BH, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. III. Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods. Regul. Toxicol. Pharmacol. 34: 274-286.
20. Hastings KL. 2001. Pre-clinical methods for detecting the hypersensitivity potential of pharmaceuticals: regulatory considerations. Toxicology 158: 85-89.
21. Hatao M, Hariya T, Katsumura Y, Kato S. 1995. A modification of the local lymph node assay for contact allergenicity screening: measurement of interleukin-2 as an alternative to radioisotope-dependent proliferation assay. Toxicology 98: 15-22.
22. ICCVAM. 2009. Independent Scientific Peer Review Panel Report: Updated Validation Status of New Versions and Applications of the Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals and Products. National Institute of Environmental Health Sciences: Research Triangle Park, NC.
23. Idehara K, Yamagishi G, Yamashita K, Ito M. 2008. Characterization and evaluation of amodified local lymph node assay using ATP content as a non-radio isotopic endpoint. J. Pharmacol. Toxicol. Meth. 58: 1-10.
24. Kimber I. 2001. The local lymph node assay and potential application to the identification of drug allergens. Toxicology 158: 59-64.
25. Kimber I, Hilton J, Botham PA, Basketter DA, Scholes EW, Miller K, Robbins MC, Harrison PT, Gray TJ, Waite SJ. 1991. The murine local lymph node assay: Results of an inter-laboratory trial. Toxicol. Lett. 55: 203-213.
26. Kimber I, Hilton J, Dearman RJ, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, Ladics GS, Loveless SE, House RV et al. 1995. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 103: 63-73.
27. Kimber I, Hilton J, Dearman RJ, Gerberick GF, Ryan CA, Basketter DA, Lea L, House RV, Ladics GS, Loveless SE, Hastings KL. 1998. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation. J. Toxicol. Environ. Health A 53: 563-579.
28. Lee JK, Park JH, Park SH, Kim HS, Oh HY. 2002. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry. J. Pharmacol. Toxicol. Meth. 48: 53-61.
29. Loveless SE, Ladics GS, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, House RV, Hilton J, Dearman RJ, Kimber I. 1996. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 108: 141-152.
30. Normand SLT. 1999. Meta-analysis: Formulating, evaluating, combining, and reporting. Stat. Med. 18: 321-359.
31. OECD. 1992. Organization for Economic Co-operation and Development - OECD Guidelines for Testing of Chemicals. No. 406: Skin Sensitization.
32. OECD. 2002. Organization for Economic Co-operation and Development - OECD Guidelines for Testing of Chemicals. No. 429: Skin Sensitization: Local Lymph Node Assay.
33. OECD. 2005. Organization for Economic Co-operation and Development - OECD Series on Testing and Assessment. No. 34: Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment.
34. Omori T, Sozu T. 2007. Variance of the stimulation index for the local lymph node assay. AATEX 12: 321-359.
35. Omori T, Idehara K, Kojima H, Sozu T, Arima K, Goto H, Hanada T, Ikarashi Y, Inoda T, Kanazawa Y, Kosaka T, Maki E, Morimoto T, Shinoda S, Shinoda N, Takeyoshi M, Tanaka M, Uratani M, Usami M, Yamanaka A, Yoneda T, Yoshimura I, Yuasa A. 2008. Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement. J. Pharmacol. Toxicol. Meth. 58: 11-26.
36. Sailstad DM, Hattan D, Hill RN, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. I. The ICCVAM review process. Regul. Toxicol. Pharmacol. 34: 249-257.
37. Scholes EW, Basketter DA, Sarll AE, Kimber I, Evans CD, Miller K, Robbins MC, Harrison PT, Waite SJ. 1992. The local lymph node assay: results of a final inter-laboratory validation under field conditions. J. Appl. Toxicol. 12: 217-222.
38. Takeyoshi M, Yamasaki K, Yakabe Y, Takatsuki M, Kimber I. 2001. Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2Vdeoxyuridine (BrdU) incorporation. Toxicol. Lett. 119: 203-208.
39. Takeyoshi M, Iida K, Shiraishi K, Hoshuyama S. 2005. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay. J. Appl. Toxicol. 5(2): 129-134.
40. Takeyoshi M, Noda S, Yamasaki K. 2006. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay. J. Appl. Toxicol. 26(1): 5-9.
41. Yamashita K, Idehara K, Fukuda N, Yamagishi G, Kawada N. 2005. Development of a modified local lymph node assay using ATP measurement as an endpoint. AATEX 11: 136-144.